# SBFM (Sunshine Biopharma Inc.) - SEC EDGAR Financial Statements

> Sunshine Biopharma Inc. reported $35.37M in revenue and a net loss of $6.17M for the trailing twelve months ended September 30, 2026 (up 0.3% year over year), with a 30.4% gross margin and a -17.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/SBFM
- Markdown: https://convexityos.com/fundamentals/SBFM.md
- SEC CIK: 0001402328
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001402328&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $35.37M | +0.3% YoY |
| Operating Income | TTM | -$6.09M | -17.2% margin |
| Net Income | TTM | -$6.17M | -17.5% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -$5.51M | -15.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $628K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $36.31M | $34.87M | $24.09M | $4.35M | $228K | $71K | $21K | $0 | $0 | $0 |
| Cost of Revenue | $24.05M | $24.20M | $15.75M | $2.65M | $118K | $26K | $11K | $0 | $0 | -- |
| **Gross Profit** | $12.26M | $10.67M | $8.34M | $1.70M | $111K | $46K | $10K | $0 | $0 | -- |
| Research & Development | $604K | $934K | $1.86M | $812K | $672K | $1.7K | $15K | $13K | $0 | $33K |
| **Operating Income** | -$6.23M | -$5.81M | -$4.79M | -$27.00M | -$2.44M | -$577K | -$642K | -$1.16M | -$857K | -$993K |
| **EBITDA** | -$5.89M | -$5.59M | -$4.64M | -$26.98M | -$2.43M | -$563K | -$628K | -$1.11M | -$851K | -$932K |
| Interest Expense | $0 | $8.8K | $137K | $39K | $329K | $168K | $116K | $143K | $105K | $35K |
| Income Before Tax | -$5.95M | -$5.37M | -$4.11M | -$26.51M | -$12.44M | -- | -- | -- | -- | -- |
| Income Tax Expense | $22K | -$235K | $395K | $233K | $0 | $0 | -- | -- | -- | -- |
| **Net Income** | -$5.98M | -$5.13M | -$4.51M | -$26.74M | -$12.44M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.50M |
| Basic EPS | -$2,880.00 | -$14,640.00 | -$702,720.00 | -$704,000,000.00 | -$1,904,000,000.00 | -$218,400,000,000.00 | -$12,000,000,000.00 | -$56,800,000,000.00 | -$32,000,000,000.00 | -$16,000,000,000.00 |
| **Diluted EPS** | -- | -$14,640.00 | -$702,720.00 | -$704,000,000.00 | -$1,904,000,000.00 | -- | -- | -- | -- | -- |
| Basic Shares Outstanding | 2.1K | 351 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted Shares Outstanding | -- | 351 | 6 | 0 | 0 | -- | -- | -- | -- | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $9.44M | $9.26M | $8.09M | $8.58M | $9.42M | $9.41M | $8.90M | $9.59M |
| Cost of Revenue | $6.34M | $6.84M | $5.91M | $5.55M | $6.34M | $5.99M | $6.17M | $6.50M |
| **Gross Profit** | $3.10M | $2.43M | $2.18M | $3.03M | $3.07M | $3.42M | $2.73M | $3.09M |
| Research & Development | $1.6K | $13K | $32K | $74K | $119K | $196K | $215K | $149K |
| **Operating Income** | -$1.29M | -$1.61M | -$1.40M | -$1.79M | -$1.09M | -$2.05M | -$1.30M | -$2.04M |
| **EBITDA** | -$1.22M | -$1.53M | -$1.32M | -$1.69M | -$991K | -$1.98M | -$1.23M | -$1.97M |
| Interest Expense | -- | -- | -- | $0 | $0 | $0 | $0 | $8.5K |
| Income Before Tax | -$1.29M | -$1.56M | -$1.24M | -$1.73M | -$1.02M | -$1.98M | -$1.22M | -$2.29M |
| Income Tax Expense | -$64K | $0 | $0 | $408K | -$137K | -$209K | -$40K | -$129K |
| **Net Income** | -$1.22M | -$1.56M | -$1.24M | -$2.14M | -$884K | -$1.77M | -$1.18M | -$2.16M |
| Basic EPS | -$5.20 | -$230.00 | -$500.00 | -- | -$38.80 | -$788.00 | -$880.00 | -- |
| **Diluted EPS** | -- | -- | -- | -- | -- | -$1,640.00 | -$880.00 | -- |
| Basic Shares Outstanding | 235.3K | 6.8K | 2.5K | -- | 22.8K | 2.2K | 1.4K | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | 1.8K | 1.4K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | $21.83M | $2.05M | $990K | $41K | $111K | $108K | $57K |
| **Cash & Short-Term Investments** | -- | -- | -- | $21.83M | $2.05M | $990K | $41K | $111K | $108K | $57K |
| Accounts Receivable, Net | $3.46M | $3.87M | $2.55M | $1.91M | $7.8K | $1.9K | $430 | $0 | $0 | -- |
| Inventory | $13.47M | $11.28M | $5.73M | $3.29M | $106K | $24K | $16K | $0 | -- | -- |
| **Total Current Assets** | $26.85M | $25.97M | $24.89M | $27.31M | $2.20M | $1.03M | $66K | $1.10M | $117K | $58K |
| Property, Plant & Equipment, Net | $557K | $546K | $366K | $394K | $7.1K | $20K | $32K | $45K | $60K | $5.9K |
| Goodwill | -- | $0 | $0 | $0 | $0 | -- | $666K | $666K | $0 | -- |
| Intangible Assets | $1.89M | $3.02M | $1.44M | $777K | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Non-Current Assets** | $3.23M | $4.59M | $2.46M | $1.93M | $7.1K | $20K | $32K | $935K | $140K | $5.9K |
| **Total Assets** | $30.08M | $30.56M | $27.35M | $29.24M | $2.20M | $1.05M | $98K | $1.15M | $257K | $64K |
| Accounts Payable | $5.66M | $5.54M | $2.59M | $2.80M | $43K | $63K | $97K | $116K | $19K | $28K |
| Other Current Liabilities | $296K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $6.44M | $6.31M | $5.55M | $6.93M | $91K | $1.05M | $834K | $912K | $751K | $274K |
| Long-Term Debt | -- | -- | -- | -- | -- | $949K | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $597K | $745K | $588K | $685K | $1.90M | $949K | $0 | $290K | $80K | $0 |
| **Total Liabilities** | $7.04M | $7.06M | $6.14M | $7.62M | $1.99M | $2.00M | $834K | $1.20M | $831K | $274K |
| **Total Debt (incl. Leases)** | $812K | $952K | $658K | $765K | -- | $949K | -- | -- | -- | -- |
| Common Stock | $25 | $2.6K | $14 | $23K | $2.6K | $1.7K | $35K | $4.3K | $46K | $769K |
| Retained Earnings | -$75.02M | -$69.04M | -$63.91M | -$59.40M | -$32.66M | -$20.22M | -$17.43M | -$15.77M | -$13.62M | -$12.58M |
| Accumulated Other Comp. Income | -$65K | -$830K | $696K | $162K | -$23K | -$2.9K | -$2.5K | -$3.7K | $504 | $394 |
| **Total Stockholders' Equity** | $23.04M | $23.50M | $21.21M | $21.63M | $212K | -$955K | -$735K | -$56K | -$573K | -$210K |
| Total Equity | $23.04M | $23.50M | $21.21M | $21.63M | $212K | -$955K | -$735K | -$56K | -$573K | -$210K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Accounts Receivable, Net | $3.89M | $4.04M | $4.01M | $3.46M | $4.16M | $3.59M | $3.45M | $3.87M |
| Inventory | $11.66M | $12.12M | $13.17M | $13.47M | $14.06M | $13.02M | $11.86M | $11.28M |
| **Total Current Assets** | $31.00M | $30.67M | $24.78M | $26.85M | $27.97M | $27.85M | $24.48M | $25.97M |
| Property, Plant & Equipment, Net | $362K | $477K | $516K | $557K | $598K | $638K | $520K | $546K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 |
| Intangible Assets | $1.89M | $1.84M | $1.92M | $1.89M | $2.01M | $2.49M | $3.19M | $3.02M |
| **Total Non-Current Assets** | $2.85M | $2.97M | $3.15M | $3.23M | $3.52M | $4.11M | $4.71M | $4.59M |
| **Total Assets** | $33.86M | $33.63M | $27.93M | $30.08M | $31.49M | $31.97M | $29.19M | $30.56M |
| Accounts Payable | -- | $4.85M | $5.10M | $5.66M | $6.14M | $4.80M | $5.02M | $5.54M |
| Other Current Liabilities | $0 | -- | -- | $296K | -- | -- | -- | -- |
| **Total Current Liabilities** | $4.79M | $5.62M | $5.88M | $6.44M | $6.65M | $5.57M | $5.76M | $6.31M |
| **Total Non-Current Liabilities** | $427K | $476K | $536K | $597K | $637K | $707K | $722K | $745K |
| **Total Liabilities** | $5.22M | $6.09M | $6.41M | $7.04M | $7.29M | $6.28M | $6.48M | $7.06M |
| **Total Debt (incl. Leases)** | $628K | $678K | $745K | $812K | $855K | $929K | $936K | $952K |
| Common Stock | $278 | $2.4K | $4.9K | $25 | $4.6K | $4.6K | $2.7K | $2.6K |
| Retained Earnings | -$79.05M | -$77.82M | -$76.26M | -$75.02M | -$72.87M | -$71.99M | -$70.22M | -$69.04M |
| Accumulated Other Comp. Income | -$640K | -$659K | -$343K | -$65K | -$321K | $281K | -$804K | -$830K |
| **Total Stockholders' Equity** | $28.64M | $27.54M | $21.52M | $23.04M | $24.20M | $25.68M | $22.70M | $23.50M |
| Total Equity | $28.64M | $27.54M | $21.52M | $23.04M | $24.20M | $25.68M | $22.70M | $23.50M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.98M | -$5.13M | -$4.51M | -$26.74M | -$12.46M | -$2.78M | -$1.66M | -$2.16M | -$1.04M | -$3.50M |
| Depreciation & Amortization | $332K | $224K | $149K | $25K | $13K | $14K | $14K | $49K | $6.6K | $61K |
| Stock-Based Compensation | -- | -- | -- | -- | -- | $272K | $277K | $755K | $520K | $499K |
| Change in Receivables | -$116K | -$2.34M | -$594K | -$524K | -$5.9K | -$1.5K | -$430 | -$15K | $0 | -- |
| Change in Inventory | -$1.64M | -$6.01M | -$2.37M | $43K | -$82K | -$7.9K | -$16K | $0 | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -$35K | -$19K | $62K | -$8.8K | -$19K |
| **Operating Cash Flow** | -$5.33M | -$12.52M | -$8.78M | -$5.25M | -$1.83M | -$657K | -$496K | -$513K | -$544K | -$314K |
| Capital Expenditure | -$174K | -$1.66M | -$82K | -$194K | $0 | -$1.2K | -$860 | -$19K | -$3.7K | -$3.4K |
| **Free Cash Flow** | -$5.51M | -$14.18M | -$8.86M | -$5.44M | -$1.83M | -$658K | -$497K | -$532K | -$547K | -$318K |
| **Investing Cash Flow** | -$836K | -$1.98M | -$656K | -$14.62M | $0 | -$1.2K | -$15K | -$14K | -$84K | -$3.4K |
| Common Stock Issued | $1.83M | $8.52M | $4.09M | $30.37M | $0 | -- | -- | $0 | $64K | $104K |
| Share Repurchases | $0 | -$3.14M | -$541K | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $4.75M | $8.94M | $3.43M | $39.47M | $2.90M | $1.61M | $442K | $528K | $671K | $325K |
| **Net Change in Cash** | -$1.42M | -$5.56M | -$6.01M | $19.60M | $1.08M | $950K | -$69K | $926 | $43K | $7.0K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.22M | -$1.56M | -$1.24M | -$2.14M | -$884K | -$1.77M | -$1.18M | -$2.16M |
| Depreciation & Amortization | $75K | $78K | $77K | $99K | $96K | $72K | $65K | $65K |
| Change in Receivables | $92K | -$89K | -$610K | $41K | -$650K | $66K | $427K | -$1.02M |
| Change in Inventory | $480K | $794K | $78K | $773K | -$1.29M | -$555K | -$569K | -$1.80M |
| **Operating Cash Flow** | -$1.38M | -$918K | -$2.07M | -$1.62M | -$747K | -$1.27M | -$1.70M | -$3.41M |
| Capital Expenditure | -- | -$7.0K | -$5.1K | $1.0K | -$8.0K | -$160K | -$7.5K | -$103K |
| **Free Cash Flow** | -- | -$925K | -$2.08M | -$1.61M | -$755K | -$1.43M | -$1.70M | -$3.51M |
| **Investing Cash Flow** | $25K | -$5.1K | -$105K | -$50K | -$24K | -$550K | -$212K | -$98K |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $1.83M | $0 | $0 |
| Share Repurchases | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Financing Cash Flow** | $2.23M | $7.80M | $0 | $724K | $0 | $3.67M | $355K | $1.62M |
| **Net Change in Cash** | $873K | $6.88M | -$2.18M | -$941K | -$771K | $1.85M | -$1.55M | -$1.88M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 33.8% | 30.6% | 34.6% | 39.0% | 48.4% | 63.8% | 47.7% | -- | -- | -- |
| **Operating Margin** | -17.2% | -16.7% | -19.9% | -621.3% | -1068.2% | -807.8% | -3037.9% | -- | -- | -- |
| **Net Profit Margin** | -16.5% | -14.7% | -18.7% | -615.4% | -5444.4% | -3898.7% | -7860.9% | -- | -- | -- |
| Return on Equity (ROE) | -25.9% | -21.8% | -21.2% | -123.7% | -5875.6% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -19.9% | -16.8% | -16.5% | -91.5% | -564.6% | -266.3% | -1691.7% | -188.1% | -404.0% | -5429.3% |
| Current Ratio | 4.17x | 4.11x | 4.48x | 3.94x | 24.07x | 0.98x | 0.08x | 1.21x | 0.16x | 0.21x |
| Quick Ratio | 2.08x | 2.33x | 3.45x | 3.47x | 22.91x | 0.95x | 0.06x | 1.21x | 0.14x | 0.21x |
| Debt to Equity | 0.04x | 0.04x | 0.03x | 0.04x | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +4.1% | +44.7% | +454.4% | +1802.4% | +219.9% | +238.1% | -- | -- | -- | -100.0% |
| Gross Profit Growth (YoY) | +14.9% | +27.9% | +391.5% | +1434.0% | +142.7% | +352.4% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 30.4% | 30.3% | 33.0% | 33.8% | 33.0% | 33.3% | 30.5% | 30.6% |
| **Operating Margin** | -17.2% | -16.6% | -17.8% | -17.2% | -17.3% | -17.9% | -15.8% | -16.5% |
| **Net Profit Margin** | -17.5% | -16.5% | -17.0% | -16.5% | -16.1% | -17.4% | -13.9% | -14.7% |
| Return on Equity (ROE) | -21.6% | -21.2% | -28.1% | -25.9% | -24.8% | -24.6% | -22.2% | -21.8% |
| Return on Assets (ROA) | -18.2% | -17.3% | -21.6% | -19.9% | -19.0% | -19.7% | -17.2% | -16.8% |
| Current Ratio | 6.47x | 5.46x | 4.22x | 4.17x | 4.20x | 5.00x | 4.25x | 4.11x |
| Quick Ratio | 4.03x | 3.30x | 1.98x | 2.08x | 2.09x | 2.66x | 2.19x | 2.33x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.04x | 0.04x | 0.04x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | +0.3% | -1.6% | -9.1% | -10.6% | +11.6% | +1.2% | +18.0% | +24.9% |
| Gross Profit Growth (YoY) | +0.9% | -29.1% | -20.1% | -2.1% | +7.2% | +45.3% | +16.0% | +20.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
